Skip to content

Solid Biosciences Inc. SLDB Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
Biogen logo
BiogenBIIB
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
uniQure logo
uniQureQURE
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.3M-43.1%
Net income-$56.7M-44.4%
EPS (diluted)-$0.52+11.9%

Balance sheet

See full
Cash & equivalents$297.1M+41.1%
Total debt$20.7M-12.5%
Total equity$374.1M+27.1%
Total assets$422.9M+23.0%

Cash flow

See full
Operating cash flow-$47.2M-48.3%
CapEx$165.0K+31.0%
Free cash flow-$47.4M-48.2%

Valuation

See full
Market cap$872.26M+135%
Enterprise value$595.83M+223%
P/S107.8×-9.9×

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-57.4%+2.2pp
Debt / equity0.1×0.0×
Current ratio13.1×+2.2×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solid Biosciences Inc.'s software and technology licenses, net?
Solid Biosciences Inc. (SLDB) reported software and technology licenses, net of $183K in Q1 2026.
How has Solid Biosciences Inc.'s software and technology licenses, net changed year-over-year?
Solid Biosciences Inc.'s software and technology licenses, net decreased by 42.6% year-over-year, from $319K to $183K.
What is the long-term trend for Solid Biosciences Inc.'s software and technology licenses, net?
Over 5 years (2020 to 2025), Solid Biosciences Inc.'s software and technology licenses, net has grown at a 1.3% compound annual growth rate (CAGR), from $209K to $223K.